サマリー

アレルギー緩和用目薬の世界市場 2022-2026 年
Technavioはアレルギー緩和点眼薬市場を監視しており、2022年から2026年の間に3億5494万ドルの成長が見込まれ、予測期間中にCAGR 4.31%で加速しています。当レポートでは、アレルギー緩和点眼薬市場の全体分析、市場規模・予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、眼感染症の高い有病率と発生率、老年人口の拡大、アレルギー性結膜炎の有病率の上昇によって牽引されています。
アレルギー緩和点眼薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioのアレルギー緩和点眼薬市場は、以下のようにセグメント化されています。
製品別
- 抗ヒスタミン剤
- 非ステロイド性抗炎症薬
- 血管収縮剤
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるアレルギー緩和点眼薬市場の成長を促進する主な理由の1つとして、ジェネリック医薬品の採用が拡大していることを挙げています。また、処方薬の高コストと目に関連する障害への配慮の高まりが、市場の大きな需要につながるでしょう。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。アレルギー緩和点眼薬市場に関する当レポートの対象領域は以下の通りです。
- アレルギー症状を緩和する目薬の市場規模
- アレルギー緩和用目薬の市場予測
- アレルギー緩和点眼薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、アステラス製薬株式会社、ボシュヘルス株式会社、ドクター・レディス・ラボラトリーズ株式会社、ジョンソン＆ジョンソンサービス株式会社、ルパン株式会社、ニコックス SA、ノバルティス AG、Ocular Therapeutix Inc、Pfizer Inc、Prestige Consumer Healthcare Inc、RohtO Pharmaceutical Co.Ltd.、Rynel Clifton Pharma Pvt.Ltd.、Santen Pharmaceutical Co.米国、スターファーマ・ホールディングス米国、スターファーマ・ホールディングス社、住友製薬株式会社、Sumitomo Pharma Co.Ltd.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.の7社です。また、アレルギー緩和目薬の市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/allergy-relieving-eye-drops-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Antihistamines - Market size and forecast 2021-2026
o Exhibit 28: Chart on Antihistamines - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Antihistamines - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Antihistamines - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Antihistamines - Year-over-year growth 2021-2026 (%)
o 5.4 Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026
o Exhibit 32: Chart on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
o 5.5 Vasoconstrictors - Market size and forecast 2021-2026
o Exhibit 36: Chart on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Product
o Exhibit 44: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 93: AbbVie Inc. - Overview
o Exhibit 94: AbbVie Inc. - Product / Service
o Exhibit 95: AbbVie Inc. - Key offerings
o 10.4 Astellas Pharma Inc.
o Exhibit 96: Astellas Pharma Inc. - Overview
o Exhibit 97: Astellas Pharma Inc. - Product / Service
o Exhibit 98: Astellas Pharma Inc. - Key news
o Exhibit 99: Astellas Pharma Inc. - Key offerings
o 10.5 Bausch Health Co. Inc.
o Exhibit 100: Bausch Health Co. Inc. - Overview
o Exhibit 101: Bausch Health Co. Inc. - Business segments
o Exhibit 102: Bausch Health Co. Inc. - Key news
o Exhibit 103: Bausch Health Co. Inc. - Key offerings
o Exhibit 104: Bausch Health Co. Inc. - Segment focus
o 10.6 Dr. Reddys Laboratories Ltd.
o Exhibit 105: Dr. Reddys Laboratories Ltd. - Overview
o Exhibit 106: Dr. Reddys Laboratories Ltd. - Business segments
o Exhibit 107: Dr. Reddys Laboratories Ltd. - Key offerings
o Exhibit 108: Dr. Reddys Laboratories Ltd. - Segment focus
o 10.7 Johnson and Johnson services Inc
o Exhibit 109: Johnson and Johnson services Inc - Overview
o Exhibit 110: Johnson and Johnson services Inc - Business segments
o Exhibit 111: Johnson and Johnson services Inc - Key news
o Exhibit 112: Johnson and Johnson services Inc - Key offerings
o Exhibit 113: Johnson and Johnson services Inc - Segment focus
o 10.8 Novartis AG
o Exhibit 114: Novartis AG - Overview
o Exhibit 115: Novartis AG - Business segments
o Exhibit 116: Novartis AG - Key offerings
o Exhibit 117: Novartis AG - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 118: Pfizer Inc. - Overview
o Exhibit 119: Pfizer Inc. - Product / Service
o Exhibit 120: Pfizer Inc. - Key news
o Exhibit 121: Pfizer Inc. - Key offerings
o 10.10 Santen Pharmaceutical Co. Ltd.
o Exhibit 122: Santen Pharmaceutical Co. Ltd. - Overview
o Exhibit 123: Santen Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 124: Santen Pharmaceutical Co. Ltd. - Key offerings
o 10.11 Sumitomo Pharma Co. Ltd.
o Exhibit 125: Sumitomo Pharma Co. Ltd. - Overview
o Exhibit 126: Sumitomo Pharma Co. Ltd. - Business segments
o Exhibit 127: Sumitomo Pharma Co. Ltd. - Key offerings
o Exhibit 128: Sumitomo Pharma Co. Ltd. - Segment focus
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 129: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 130: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 131: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 132: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 133: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 134: Inclusions checklist
o Exhibit 135: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 136: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 137: Research methodology
o Exhibit 138: Validation techniques employed for market sizing
o Exhibit 139: Information sources
o 11.5 List of abbreviations
o Exhibit 140: List of abbreviations
o sales: Price when sold from manufacturer to wholesaler or directly to pharmacies as reported by vendors in the industry. The market size excludes all discounts and allowances, returns, chargebacks, and government rebates such as Medicaid and Medicare.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Antihistamines - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Antihistamines - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Antihistamines - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Antihistamines - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Non-steroidal anti-Inflammatory drugs - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Non-steroidal anti-Inflammatory drugs - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Vasoconstrictors - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Vasoconstrictors - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Astellas Pharma Inc. - Overview
Exhibits97: Astellas Pharma Inc. - Product / Service
Exhibits98: Astellas Pharma Inc. - Key news
Exhibits99: Astellas Pharma Inc. - Key offerings
Exhibits100: Bausch Health Co. Inc. - Overview
Exhibits101: Bausch Health Co. Inc. - Business segments
Exhibits102: Bausch Health Co. Inc. - Key news
Exhibits103: Bausch Health Co. Inc. - Key offerings
Exhibits104: Bausch Health Co. Inc. - Segment focus
Exhibits105: Dr. Reddys Laboratories Ltd. - Overview
Exhibits106: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits107: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits108: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits109: Johnson and Johnson services Inc - Overview
Exhibits110: Johnson and Johnson services Inc - Business segments
Exhibits111: Johnson and Johnson services Inc - Key news
Exhibits112: Johnson and Johnson services Inc - Key offerings
Exhibits113: Johnson and Johnson services Inc - Segment focus
Exhibits114: Novartis AG - Overview
Exhibits115: Novartis AG - Business segments
Exhibits116: Novartis AG - Key offerings
Exhibits117: Novartis AG - Segment focus
Exhibits118: Pfizer Inc. - Overview
Exhibits119: Pfizer Inc. - Product / Service
Exhibits120: Pfizer Inc. - Key news
Exhibits121: Pfizer Inc. - Key offerings
Exhibits122: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits123: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits124: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits125: Sumitomo Pharma Co. Ltd. - Overview
Exhibits126: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits127: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits128: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits129: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits130: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits131: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits132: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits133: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits134: Inclusions checklist
Exhibits135: Exclusions checklist
Exhibits136: Currency conversion rates for US$
Exhibits137: Research methodology
Exhibits138: Validation techniques employed for market sizing
Exhibits139: Information sources
Exhibits140: List of abbreviations